Drupal.behaviors.print = function(context) {window.print();window.close();}>
Opko Acquires Brazilian Pharma Company, Clearing Way for Launch of 4kscore Prostate Cancer Test
February 22, 2013
Opko Acquires Brazilian Pharma Company, Clearing Way for Launch of 4kscore Prostate Cancer Test
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Opko to Purchase OURLab CLIA Lab to Support US Launch of 4Kscore Prostate Cancer Dx
October 26, 2012 / ProteoMonitor
IHT Begins Selling Opko's Protein Biomarker Prostate Cancer Dx
October 5, 2012 / ProteoMonitor
Opko Acquires CLIA Lab
December 18, 2012 / GenomeWeb Daily News
Opko Health Revamping Peptoid-Based Diagnostic Platform, Prepping Alzheimer's Test for Market
July 27, 2012 / ProteoMonitor
Opko Licenses Protein Biomarker Panel for Prostate Cancer to IHT
May 4, 2012 / GenomeWeb Daily News